透明质酸隆胸术后的隆乳术
Augmentation Mammaplasty After Breast Enhancement With Hyaluronic Acid.
作者信息
Trignano Emilio, Rusciani Antonio, Armenti Andrea Felice, Corrias Federico, Fallico Nefer
机构信息
Drs Trignano and Rusciani are Consultants and Dr Fallico is a Resident in the Department of Plastic and Reconstructive Surgery, Sapienza University of Rome, Italy; Dr Trignano also is a Consultant for the Department of Plastic and Reconstructive Surgery, University of Sassari, Italy; Dr Armenti is a Consultant for the Department of Plastic and Reconstructive Surgery, University of Rome Tor Vergata, Italy; Dr Corrias is a Consultant for the Department of Plastic and Reconstructive Surgery, Monserrato University Hospital, Italy.
出版信息
Aesthet Surg J. 2015 Aug;35(6):NP161-8. doi: 10.1093/asj/sjv042. Epub 2015 Apr 24.
BACKGROUND
Macrolane is a stabilized, hyaluronic acid-based gel that has been available since 2007 as a minimally invasive, nonpermanent option for breast enhancement. However, numerous controversies pertaining to its side effects have highlighted the need for studies involving larger groups of patients.
OBJECTIVES
The authors sought to determine complications of Macrolane injections for breast enhancement and performed surgical evacuation of cysts comprising collections of hyaluronic acid in patients who previously received Macrolane treatment and presented for augmentation mammaplasty.
METHODS
The authors reviewed a case series of 20 patients who were treated elsewhere with intramammary injection of Macrolane for cosmetic purposes and who presented at the authors' medical studio with multiple intramammary and intramuscular cysts. All patients underwent surgical evacuation of the hyaluronic acid-based cysts in association with augmentation mammaplasty.
RESULTS
Good aesthetic results were achieved in all patients. Three months after surgery, 15 of 20 (75%) patients rated themselves as very much improved; 4 patients (20%) rated themselves as moderately improved, and 1 patient (5%) rated herself as somewhat improved.
CONCLUSIONS
The authors suggest that Macrolane cannot be considered a valid alternative for breast augmentation at this time.
LEVEL OF EVIDENCE
4 Therapeutic.
背景
麦罗莲（Macrolane）是一种稳定的、基于透明质酸的凝胶，自2007年以来一直作为一种微创、非永久性的隆胸选择。然而，众多关于其副作用的争议凸显了开展涉及更大患者群体研究的必要性。
目的
作者试图确定麦罗莲注射隆胸的并发症，并对先前接受过麦罗莲治疗且前来进行隆乳术的患者中包含透明质酸聚积物的囊肿进行手术引流。
方法
作者回顾了一个病例系列，其中20例患者曾在其他地方接受过麦罗莲乳房内注射以达到美容目的，这些患者在作者的医疗工作室出现了多个乳房内和肌肉内囊肿。所有患者在隆乳术的同时接受了基于透明质酸囊肿的手术引流。
结果
所有患者均获得了良好的美学效果。术后三个月，20例患者中有15例（75%）认为自己改善非常明显；4例患者（20%）认为自己有中度改善，1例患者（5%）认为自己有一定程度的改善。
结论
作者认为目前麦罗莲不能被视为隆胸的有效替代方法。
证据级别
4级治疗性。
Zotero 插件